Cog-RAST: Effects of Cognitive Training on Academic Task Performance in Attention Deficit Hyperactivity Disorder (ADHD)

Sponsor
University of California, Davis (Other)
Overall Status
Completed
CT.gov ID
NCT01124721
Collaborator
(none)
26
1
2
60
0.4

Study Details

Study Description

Brief Summary

Impaired WM is a central deficit in ADHD. A computerized training program, Cogmed, has been shown to increase WM capacity in children with ADHD. It is not known whether the training improves behavior associated with classroom learning, such as remaining on-task and inhibiting off- task behavior. The aim of this study is to utilize ecologically valid measures to investigate training's effect on observable ADHD behavior in conjunction with more standard measures. Subjects will be randomly assigned to a Cogmed versus an active "placebo" condition in which the tasks do not increase in difficulty level in a double-blinded fashion. The effects of the active Cogmed versus placebo computer training will be compared on measures in children with ADHD.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive training
  • Behavioral: Cognitive training-placebo
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
26 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
Pilot Testing of Cognitive Training on Academic Task Performance in Children With Attention-deficit/Hyperactivity Disorder
Study Start Date :
Jan 1, 2008
Actual Primary Completion Date :
Jan 1, 2013
Actual Study Completion Date :
Jan 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cogmed cognitive training

Computerized working memory, attention and cognitive tasks

Behavioral: Cognitive training
Cognitive computerized training for several days per week.
Other Names:
  • Cogmed
  • Active Comparator: Active placebo

    Cognitive training, however the training does not increase in difficulty, or does so to a minimal degree.

    Behavioral: Cognitive training-placebo
    Cognitive training that only minimally increases in difficulty
    Other Names:
  • Cogmed placebo
  • Outcome Measures

    Primary Outcome Measures

    1. Restricted Academic Situations Task [6 weeks]

      Assessment of on-task type behavior while doing a simulated academic task.

    2. Working memory measures [6 weeks]

      Assess memory and working memory functioning on computer and or RA administered tests.

    3. Rating scales [6 weeks]

      Parent and teacher ratings of behavior and attention

    Secondary Outcome Measures

    1. Fluency and attention measures [6 weeks]

      Measures of fluency and attentional functioning.

    2. Self-control and executive functioning measures [6 weeks]

      Attention and working memory components can affect delay discounting and self-control measures. This measure will assess for change in behavior and ratings associated with executive functioning.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    7 Years to 14 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Age range 7-14

    2. At least average academic and intellectual functioning via parent report.

    3. Must have ADHD (by parent report of previous diagnosis or per telephone screening checklist - to be confirmed via interview and ratings)

    4. Attentional, hyperactive or impulsive symptoms that interfere with functioning.

    Exclusion Criteria:
    1. Diagnosis of severe mental illness for example, psychotic, bipolar or major depressive disorder, (by history)

    2. Mental retardation (by history)

    3. English is not the primary language

    4. Family does not have a computer

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UCaliforniaDavis MIND Institute Sacramento California United States 95825

    Sponsors and Collaborators

    • University of California, Davis

    Investigators

    • Principal Investigator: Julie Schweitzer, PhD, University of California, Davis

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of California, Davis
    ClinicalTrials.gov Identifier:
    NCT01124721
    Other Study ID Numbers:
    • 200816598
    First Posted:
    May 17, 2010
    Last Update Posted:
    May 31, 2017
    Last Verified:
    May 1, 2017
    Keywords provided by University of California, Davis
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 31, 2017